CoWIN

Last updated

Co-WIN
Logo of CoWIN.svg
Type of site
National government portal
Available in English, Hindi, Marathi, Malayalam, Bengali, Kannada, Telugu, Tamil, Punjabi, Odia, Assamese, Gujarati
Owner Government of India
URL cowin.gov.in
CommercialNo
RegistrationRequired
Launched16 January 2021;3 years ago (2021-01-16) [1]
Current statusActive

CoWIN (Covid Vaccine Intelligence Network) is an Indian government web portal for COVID-19 vaccination registration, owned and operated by India's Ministry of Health and Family Welfare. It displays booking slots of COVID-19 vaccine available in the nearby areas and can be booked on the website. The site also provides vaccination certificates to the beneficiaries, which act as Vaccine Passports during the COVID-19 pandemic for the beneficiaries and can be stored in Digilocker. [2] Users can access the platform via desktop, tablet, and mobile phones. [3]

Contents

About

CoWIN serves the function of registration, appointment scheduling, identity verification, vaccination and certification of each vaccinated member. [4] Registration for the vaccination slots can be booked on the same day or a few days prior. The platform has also been integrated in the Aarogya Setu and UMANG Apps. The certificate after COVID-19 vaccination can also be obtained through the platform. To expedite the development of this platform, several existing digital assets were leveraged, such as: Electronic Vaccine Intelligence Network (eVIN),Digital Infrastructure for Vaccination Open Credentialing (DIVOC), DigiLocker, Surveillance and Action for Events Following Vaccination (SAFE-VAC). CoWIN application was developed with five modules: the orchestration module; the vaccination cold chain module; the citizen registration module; the vaccinator module; and the certificate, feedback, and adverse event following immunization reporting module. [5] As of now, eight vaccines can be registered on the platform in the country Covishield (18+), Covaxin (15+), Corbevax (12-14), Sputnik V (18+), Corbevax (12-14), Gemcovac (18+) Incovacc (18+), ZyCoV-D (18+) and Covovax (12+). [6]

In the future, the Health ministry is working on upgrading CoWIN for the effective implementation of India's universal immunization programme. Co-WIN platform will be used for booking slots for the routine vaccinations like Polio and Hepatitis. This will allow healthcare professionals to digitally track the immunization status of beneficiaries (mother and children) on a real-time basis and address the vaccination needs immediately. [7]

Doctors and medical professionals may soon be able to manage appointments and maintain patient records over the vaccine platform CoWIN, with the National Health Authority (NHA) integrating it with the Ayushman Bharat Digital Health Mission (ABDM)—the backbone of India's digital healthcare system. This lightweight health management information system (HMIS) solution will allow small clinics and providers to manage appointments, patient information and prescriptions. The HMIS will be integrated with all ABDM modules and allow the doctor and clinic to create a health professional ID and a health facility ID [8]

History

Prime Minister, Narendra Modi had envisioned roll-out of a technology based citizen facing platform for smooth running of COVID-19 vaccination in India, long back in May 2020. The government repurposed its eVIN platform and tested it in more than 700 districts before the launch of CoWIN. However, the PM sensed that the technological backbone would need more robustness and decided to revive the team that had delivered Aadhaar and brought Dr RS Sharma [9] on board who previously headed the Telecom Regulatory Authority of India and the Unique Identification Authority of India. Within days, Sharma was appointed Chair of the Empowered Group of technology and Data management and member of National Expert Group on Vaccine Administration(NEGVAC), a body constituted by the Government of India and also the CEO of the National Health Authority (NHA). [10]

CoWIN software was designed by Trigyn Technologies and KPMG India was hosted on Amazon Web Services. [11]

On 16 January 2021, CoWIN was launched and started offering COVID-19 vaccination for Frontline Workers in the country. [12]

On 1 March 2021, the platform started offering vaccination to all residents over the age of 60, residents between the ages of 45 and 60 with one or more qualifying comorbidities, and any health care or frontline worker that did not receive a dose during phase 1. [13]

From 1 April 2021, eligibility was extended to all residents over the age of 45. [14] Registration for the next phase began on 28 April 2021 for 1 May 2021, extending eligibility to all residents over the age of 18. [15]

On 28 June 2021, it was announced that an open source version will be given to over 50 interested countries. [16] CoWIN has been the fastest growing tech platform in the world. India has also signed an MoU with the government of the Co-operative Republic of Guyana for sharing CoWIN. [17] [18]

On 17 September 2021, CoWIN handled the volume of 25 million doses in 24 hours without any glitches. [19]

On 21 October 2021, according to the CoWIN portal, India crossed 1 billion doses. [20]

From 3 January 2022, eligibility was extended for the citizens above 15 years of age, for which registration started from 1 January 2022, on CoWIN. Currently Covaxin, Corbevax, Covovax vaccine is approved for 15-18 age group. [21] [22]

From 10 January 2022, COVID booster dose drive has been started for frontline workers, 60+ people with comorbidities, healthcare workers and workers on election duty. Either they can visit the vaccination center or book the slot on CoWIN Platform. Booster (precaution dose) will only be given with same shots as prior, and there should be gap of nine to twelve months from 2nd shot. [23]

India crossed a mark of administering 2 billion vaccinations in July, 2022 which includes, dose 1, 2 and precaution dose. [24]

As of January 2023, there are more than 1 billion registrations on the CoWIN Portal, with 5132 public and private health facilities providing slots for vaccinations. [25]

See also

Related Research Articles

<span class="mw-page-title-main">Ram Sewak Sharma</span>

Ram Sewak Sharma is a retired Indian bureaucrat and former civil servant. From February 2021, he served as the Chief Executive Officer of the National Health Authority, an Indian governmental organisation tasked with managing public health insurance till February 2023. Previously, he has headed the Telecom Regulatory Authority of India, and the Unique Identification Authority of India.

<span class="mw-page-title-main">COVID-19 pandemic in Benin</span>

The COVID-19 pandemic in Benin was a part of the ongoing worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have reached Benin in March 2020.

The first case of the COVID-19 pandemic in the Indian state of Haryana was reported on 4 March 2020. The Ministry of Health and Family Welfare has confirmed a total of 2,64,955 positive cases as of 10 January 2021 out of which 2,510 are still active and 2,950 deaths so far. The recovery rate in Haryana is 97.9%.

The first case of the COVID-19 pandemic in India was reported on 30 January 2020, originating from China. Slowly, the pandemic spread to various states and union territories including the state of Tripura. The first case was recorded in this region on 6 April.

The first case of the COVID-19 pandemic was confirmed in the Indian state of Odisha on 16 March 2020. The state has confirmed 10,00,084 cases, including 9,497 active cases, 9,83,245 recoveries, and 7,289 deaths as of 21 August 2021.

The first case of the COVID-19 pandemic in India was reported on 30 January 2020, originating from China. Slowly, the pandemic spread to various states and union territories including the state of Telangana. The first case was recorded in this region on 2 March from a man who had travel history with the UAE.

The first case of the COVID-19 pandemic in India was reported on 30 January 2020, originating from China. Slowly, the pandemic spread to various states and union territories including the union territory of Chandigarh. The first case was recorded in this region on 19 March 2020. As on 24 May, total number of cases in Chandigarh was 225. This contains 43 active cases as 179 successfully recovered from it and three died from the virus.

The first case of the COVID-19 pandemic in India was reported on 30 January 2020, originating from China. Slowly, the pandemic spread to various states and union territories including the union territory of Andaman and Nicobar Islands. The first case was recorded in this region on 26 March 2020. The islands have pursued a strategy of zero COVID-19 transmission, which, except for three flareups in August 2020, May 2021, and January 2022, which were swiftly contained, have resulted in no community outbreaks. The islands have successfully managed the outbreaks, and the union territory has the lowest case count of any region of India, both in total cases and infection rate.

The first case of the COVID-19 pandemic in India was reported on 30 January 2020, originating from China. Slowly, the pandemic spread to various states and union territories including the union territory of Puducherry. The first case was recorded in this region on 17 March.

<span class="mw-page-title-main">COVAX</span> Initiative to provide COVID-19 vaccines

COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by the GAVI vaccine alliance, the Coalition for Epidemic Preparedness Innovations (CEPI), and the World Health Organization (WHO), alongside key delivery partner UNICEF. It is one of the four pillars of the Access to COVID-19 Tools Accelerator, an initiative begun in April 2020 by the WHO, the European Commission, and the government of France as a response to the COVID-19 pandemic. COVAX coordinates international resources to enable low-to-middle-income countries equitable access to COVID-19 tests, therapies, and vaccines. UNICEF is the key delivery partner, leveraging its experience as the largest single vaccine buyer in the world and working on the procurement of COVID-19 vaccine doses, as well as logistics, country readiness and in-country delivery.

<span class="mw-page-title-main">Covaxin</span> Vaccine against COVID-19

Covaxin is a whole inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research - National Institute of Virology.

The COVID-19 vaccination program in the Philippines was a mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the pandemic in the country. The vaccination program was initiated by the Duterte administration on March 1, 2021, a day after the arrival of the country's first vaccine doses which were donated by the Chinese government.

<span class="mw-page-title-main">COVID-19 vaccination in India</span> Immunisation programme against COVID-19 in India

India began administration of COVID-19 vaccines on 16 January 2021. As of 4 March 2023, India has administered over 2.2 billion doses overall, including first, second and precautionary (booster) doses of the currently approved vaccines. In India, 95% of the eligible population (12+) has received at least one shot, and 88% of the eligible population (12+) is fully vaccinated.

<span class="mw-page-title-main">COVID-19 vaccination in South Africa</span> Plan to immunize against COVID-19 in South Africa

COVID-19 vaccination in South Africa is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

<span class="mw-page-title-main">Vaccine Maitri</span> Vaccination initiative by the Indian government

Vaccine Maitri is a humanitarian initiative undertaken by the Indian government to provide COVID-19 vaccines to countries around the world. The government started providing vaccines from 20 January 2021. As of 21 February 2022, India had delivered around 16.29 crore doses of vaccines to 96 countries. Of these, 1.43 crore doses were gifted to 98 countries by the Government of India. The remaining 10.71 crore were supplied by the vaccine producers under its commercial and 4.15 crore were supplied by COVAX obligations. In late March 2021, the Government of India temporarily froze exports of the Covishield, citing India's own COVID crisis and the domestic need for these vaccines. The Health Minister of India, Mansukh Mandaviya announced in September that India will resume the export of vaccines from October to the rest of the world.

<span class="mw-page-title-main">COVID-19 vaccination in Bangladesh</span> Immunisation programme against COVID-19 in Bangladesh

Bangladesh began the administration of COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021.

<span class="mw-page-title-main">COVID-19 vaccination in Brazil</span> Plan to immunize against COVID-19

The COVID-19 vaccination campaign in Brazil is an ongoing mass immunization campaign for the COVID-19 pandemic in Brazil. It started on January 17, 2021, when the country had 210 thousand deaths.

<span class="mw-page-title-main">COVID-19 vaccine card</span> Medical record for COVID-19 vaccination

A COVID-19 vaccine card is a record often given to those who have received a COVID-19 vaccine showing information such as the date(s) one has received the shot(s) and the brand of vaccine one has received, sometimes including the lot number. The card also contains information identifying the recipient and the location where the shot was given. Depending on the country, it could serve as an official document verifying one has received vaccination, which could be required by some institutions, such as a school or workplace, when boarding a cruise ship, or when crossing an international border, as proof that one has been vaccinated.

<span class="mw-page-title-main">Covaxgate</span> Vaccine controversy in Brazil

The Case Covaxin, also known as Covaxgate, refers to an investigation made by the Brazilian Federal Public Ministry (MPF), held on June 16, 2021, which found evidence of irregularities in the purchase of 20 million doses by the Ministry of Health of the Indian vaccine Covaxin, with the value of the vaccines 1000% higher than initially foreseen.

References

  1. ↑ "PM Narendra Singh Modi To Launch CoWin App On January 16, Virtually Kickoff India's Vaccination Drive". Moneycontrol.
  2. ↑ "Traveling abroad? Here is how to link Covid-19 Vaccination certificate with passport". HT Tech. 20 July 2022. Retrieved 21 July 2022.
  3. ↑ "CoWIN in India: The Digital Backbone for the COVID-19 Vaccination Program". www.exemplars.health. Retrieved 11 January 2023.
  4. ↑ "CoWIN in India: The Digital Backbone for the COVID-19 Vaccination Program". www.exemplars.health. Retrieved 11 January 2023.
  5. ↑ "CoWIN in India: The Digital Backbone for the COVID-19 Vaccination Program". www.exemplars.health. Retrieved 11 January 2023.
  6. ↑ "CoWIN". www.cowin.gov.in. Retrieved 11 January 2023.
  7. ↑ "Exclusive | CoWIN to Be Used to Book Polio, Hepatitis, Other Routine Vaccines for Kids, Says RS Sharma". News18. 29 July 2022. Retrieved 11 January 2023.
  8. ↑ Sharma, Priyanka (16 December 2022). "CoWIN may help docs track appointments, patient data". mint. Retrieved 11 January 2023.
  9. ↑ www.ETGovernment.com. "R S Sharma to be new CEO of National Health Authority, Government News, ET Government". ETGovernment.com. Retrieved 11 January 2023.
  10. ↑ "How India Braved Covid 'Viral Storm'; Book Reveals PM's Belief in CoWIN, A Call to A Retired IAS Officer". News18. 8 January 2023. Retrieved 11 January 2023.
  11. ↑ "Inside the building and breaking of CoWIN".
  12. ↑ "World's largest vaccination programme begins in India on January 16". The Hindu. 15 January 2021. Retrieved 16 January 2021.
  13. ↑ "Coronavirus Registration for next phase of vaccination on Co-WIN 2.0 portal to open on March 1". The Hindu. 28 February 2021.
  14. ↑ "CoWin Upgrade, 50 lakh Daily Target: What to Expect As India Vaccinates Citizens Above 45". www.news18.com. 3 April 2021. Retrieved 27 April 2021.
  15. ↑ "Around 1.33 Crore Apply For Covid Vaccination: 10 Points". NDTV.com. Retrieved 1 May 2021.
  16. ↑ Perappadan, Bindu Shajan (28 June 2021). "CoWIN open-source version to be given to 50 nations". The Hindu.
  17. ↑ Chandna, Himani (5 July 2021). "CoWin goes global, 76 countries want to use India's Covid vaccination platform software". ThePrint. Retrieved 11 January 2023.
  18. ↑ Perappadan, Bindu Shajan (23 July 2022). "CoWIN platform 'know-how' now available free of cost to any country". The Hindu. ISSN   0971-751X . Retrieved 11 January 2023.
  19. ↑ "How India Braved Covid 'Viral Storm'; Book Reveals PM's Belief in CoWIN, A Call to A Retired IAS Officer". News18. 8 January 2023. Retrieved 11 January 2023.
  20. ↑ "100-crore mark! Here's how India celebrated Covid-19 vaccination milestone". Livemint. 21 October 2021. Archived from the original on 21 October 2021. Retrieved 22 October 2021.
  21. ↑ "15-17 age group to get Covaxin from January 3". The Hindu. 27 December 2021.
  22. ↑ "CoWIN". www.cowin.gov.in. Retrieved 11 January 2023.
  23. ↑ "From vaccine for kids to third shots for healthcare workers and older adults: 3 key announcements about India's COVID vaccination drive". The Times of India. 26 December 2021. Retrieved 12 January 2022.
  24. ↑ "India crosses 200 crore Covid-19 vaccinations: Day to remember forever, says Health Minister Mansukh Mandaviya". The Indian Express. 17 July 2022. Retrieved 11 January 2023.
  25. ↑ "CoWIN Dashboard". dashboard.cowin.gov.in. Retrieved 11 January 2023.

ref> "CoWIN". www.cowin.gov.in. Retrieved 11 January 2023.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.